Abstract
Acute pulmonary embolism (PE) is a life-threatening condition with high mortality rates and potential long-term sequelae. Systemic thrombolysis has been virtually the only therapeutic option available for patients with hemodynamic instability over decades. Recently, interventional therapy of PE has gained increasing interest. Multiple devices were developed; these include devices for local thrombolysis, thrombus fragmentation, thrombus aspiration, and combined approaches. However, the available evidence is limited to mostly small, nonrandomized studies. In these studies, safety and efficacy data from patients with intermediate or high-risk PE are promising. However, due to the lack of adequately powered randomized trials, interventional treatment of intermediate or high-risk PE cannot be recommended as standard-of-care. The decision on whether and how to perform a catheter-based intervention should therefore be left to the discretion of the local team, depending on the patients’ clinical status, bleeding risk, local expertise, and available devices. The implementation of local multidisciplinary PE response teams is recommended by international guidelines to provide the best possible treatment.
Zusammenfassung
Die akute Lungenembolie ist eine lebensbedrohliche Erkrankung mit hoher Mortalität und möglichen Langzeitfolgen. Über Jahrzehnte war die systemische Thrombolyse die einzige therapeutische Option bei Patienten mit hämodynamischer Instabilität. Die interventionelle Therapie der Lungenembolie gewinnt zunehmend an Bedeutung. Aktuell zugelassene katheterbasierte Verfahren umfassen die lokale Thrombolyse, Thrombusfragmentierung, Thrombusaspiration und kombinierte Methoden. Die verfügbare Evidenz beschränkt sich meist auf kleine, nichtrandomisierte Studien. In diesen Studien sind die Sicherheits- und Wirksamkeitsdaten bei Patienten mit intermediärer oder Hochrisikolungenembolie vielversprechend. Aufgrund des Mangels an aussagekräftigen randomisierten Studien kann die interventionelle Behandlung der Lungenembolie bei Patienten mit erhöhtem oder hohem Risiko jedoch nicht als Standardbehandlung empfohlen werden. Die Entscheidung, ob und wie eine kathetergestützte Intervention durchgeführt wird, sollte daher dem Ermessen des lokalen Teams überlassen werden, abhängig vom klinischen Status des Patienten, dem Blutungsrisiko, der lokalen Expertise und den verfügbaren Geräten. Die Implementierung lokaler multidisziplinärer Lungenembolie-Teams wird von internationalen Leitlinien empfohlen, um die bestmögliche Behandlung zu gewährleisten.
Similar content being viewed by others
References
Wendelboe AM, Raskob GE (2016) Global burden of thrombosis: epidemiologic aspects. Circ Res 118(9):1340–1347
Keller K, Hobohm L, Ebner M et al (2020) Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur Heart J 41(4):522–529
Cohen AT, Agnelli G, Anderson FA et al (2007) Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 98(4):756–764
de Miguel-Diez J, Jimenez-Garcia R, Jimenez D et al (2014) Trends in hospital admissions for pulmonary embolism in Spain from 2002 to 2011. Eur Respir J 44(4):942–950
Lehnert P, Lange T, Moller CH et al (2018) Acute pulmonary embolism in a national Danish cohort: increasing incidence and decreasing mortality. Thromb Haemost 118(3):539–546
Goldhaber SZ, Visani L, De Rosa M (1999) Acute pulmonary embolism: clinical outcomes in the international cooperative pulmonary embolism registry (ICOPER). Lancet 353(9162):1386–1389
Becattini C, Agnelli G, Lankeit M et al (2016) Acute pulmonary embolism: mortality prediction by the 2014 European society of cardiology risk stratification model. Eur Respir J 48(3):780–786
Konstantinides SV, Meyer G (2019) The 2019 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 40(42):3453–3455
Jaff MR, McMurtry MS, Archer SL et al (2011) Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American heart association. Circulation 123(16):1788–1830
Chatterjee S, Chakraborty A, Weinberg I et al (2014) Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA 311(23):2414–2421
Tajima H, Murata S, Kumazaki T et al (2004) Hybrid treatment of acute massive pulmonary thromboembolism: mechanical fragmentation with a modified rotating pigtail catheter, local fibrinolytic therapy, and clot aspiration followed by systemic fibrinolytic therapy. AJR Am J Roentgenol 183(3):589–595
Mohan B, Aslam N, Kumar Mehra A et al (2014) Impact of catheter fragmentation followed by local intrapulmonary thrombolysis in acute high risk pulmonary embolism as primary therapy. Indian Heart J 66(3):294–301
Schmitz-Rode T, Janssens U, Duda SH et al (2000) Massive pulmonary embolism: percutaneous emergency treatment by pigtail rotation catheter. J Am Coll Cardiol 36(2):375–380
Kuo WT, Gould MK, Louie JD et al (2009) Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. J Vasc Interv Radiol 20(11):1431–1440
Dumantepe M, Teymen B, Akturk U, Seren M (2015) Efficacy of rotational thrombectomy on the mortality of patients with massive and submassive pulmonary embolism. J Card Surg 30(4):324–332
Bayiz H, Dumantepe M, Teymen B, Uyar I (2015) Percutaneous aspiration thrombectomy in treatment of massive pulmonary embolism. Heart Lung Circ 24(1):46–54
Chechi T, Vecchio S, Spaziani G et al (2009) Rheolytic thrombectomy in patients with massive and submassive acute pulmonary embolism. Catheter Cardiovasc Interv 73(4):506–513
Li K, Cui M, Zhang K et al (2020) Treatment of acute pulmonary embolism using rheolytic thrombectomy. EuroIntervention 17(2):e158–e166
Giri J, Sista AK, Weinberg I et al (2019) Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence: a scientific statement from the American heart association. Circulation 140(20):e774–e801
Kuo WT, Banerjee A, Kim PS et al (2015) Pulmonary embolism response to fragmentation, embolectomy, and catheter thrombolysis (PERFECT): initial results from a prospective multicenter registry. Chest 148(3):667–673
Macovei L, Presura RM, Magopet R et al (2020) Local thrombolysis in high-risk pulmonary embolism-13 years single-center experience. Clin Appl Thromb Hemost 26:1076029620929764
Andresen M, Gonzalez A, Mercado M et al (2012) Natriuretic peptide type‑B can be a marker of reperfusion in patients with pulmonary thromboembolism subjected to invasive treatment. Int J Cardiovasc Imaging 28(3):659–666
Yoo JW, Choi HC, Lee SJ et al (2016) Comparison between systemic and catheter thrombolysis in patients with pulmonary embolism. Am J Emerg Med 34(6):985–988
Gaba RC, Gundavaram MS, Parvinian A et al (2014) Efficacy and safety of flow-directed pulmonary artery catheter thrombolysis for treatment of submassive pulmonary embolism. AJR Am J Roentgenol 202(6):1355–1360
Macovei L, Presura RM, Arsenescu Georgescu C (2015) Systemic or local thrombolysis in high-risk pulmonary embolism. Cardiol J 22(4):467–474
Piazza G, Hohlfelder B, Jaff MR et al (2015) A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study. JACC Cardiovasc Interv 8(10):1382–1392
Kucher N, Boekstegers P, Muller OJ et al (2014) Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 129(4):479–486
Tapson VF, Sterling K, Jones N et al (2018) A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism: the OPTALYSE PE trial. JACC Cardiovasc Interv 11(14):1401–1410
Avgerinos E (2020) Results from SUNSET sPE study: standard vs. ultrasound-assisted catheter thrombolysis. Vascular Interventional Advances Conference.
Avgerinos ED, Saadeddin Z, Abou Ali AN et al (2018) A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism. J Vasc Surg Venous Lymphat Disord 6(4):530–540
Pei DT, Liu J, Yaqoob M et al (2019) Meta-analysis of catheter directed ultrasound-assisted thrombolysis in pulmonary embolism. Am J Cardiol 124(9):1470–1477
Sista AK, Horowitz JM, Tapson VF et al (2021) Indigo aspiration system for treatment of pulmonary embolism: results of the EXTRACT-PE trial. JACC Cardiovasc Interv 14(3):319–329
Resnick SA, O’Brien D, Strain D et al (2016) Single-center experience using AngioVac with extracorporeal bypass for mechanical thrombectomy of atrial and central vein thrombi. J Vasc Interv Radiol 27(5):723–729.e1
Donaldson CW, Baker JN, Narayan RL et al (2015) Thrombectomy using suction filtration and veno-venous bypass: single center experience with a novel device. Catheter Cardiovasc Interv 86(2):E81–7
Al-Hakim R, Park J, Bansal A et al (2016) Early experience with AngioVac aspiration in the pulmonary arteries. J Vasc Interv Radiol 27(5):730–734
Wible BC, Buckley JR, Cho KH et al (2019) Safety and efficacy of acute pulmonary embolism treated via large-bore aspiration mechanical thrombectomy using the Inari FlowTriever device. J Vasc Interv Radiol 30(9):1370–1375
Tu T, Toma C, Tapson VF et al (2019) A prospective, single-arm, multicenter trial of catheter-directed mechanical thrombectomy for intermediate-risk acute pulmonary embolism: the FLARE study. JACC Cardiovasc Interv 12(9):859–869
Catalin T (2020) Abstract 16623: interim acute and 30-day results of the flash registry. Circulation 142(3):A16623
Meyer G, Vicaut E, Danays T et al (2014) Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 370(15):1402–1411
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
D. S. Sulimov, A. Freund and H. Thiele declare that they have no competing interests.
For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.
Additional information
D. S. Sulimov and A. Freund contributed equally to this article.
Rights and permissions
About this article
Cite this article
Sulimov, D.S., Freund, A. & Thiele, H. Catheter-directed therapy in pulmonary embolism. Herz 46, 399–405 (2021). https://doi.org/10.1007/s00059-021-05059-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00059-021-05059-6
Keywords
- Venous thromboembolism
- Pulmonary embolism
- Thrombolytic therapy
- Interventional treatment
- Pulmonary thrombectomy